Nucleos(t)ide analog (NUC) treatment of hepatitis B: Can we stop therapy?

(1) Medizin. Hochschule Hannover - Dr., Medizin. Hochschule Hannover; Hannover/DE

Premium Content

Please purchase any of the premium collections shown to access this library item.


View all of your premium content purchases in myUEG > My Learning.
If you need help or have questions, please contact e-learning@ueg.eu


This item was part of the Viral hepatitis: Moving towards elimination session at UEG Week 2017

You may be interested in:

Hepatitis B: When to stop therapy with nucleos(t)ide analogues
English, Presentation, Hepatobiliary, 2015, Chairman's Choice, Immunology, Primary Care
Hepatitis B: Is it possible to stop treatment?
Presentation, 2014, Hepatobiliary
Nucleos(t)ide analog (NUC) treatment of hepatitis B: Can we stop therapy?
English, Presentation, Hepatobiliary, Chairman's Choice, Primary Care, 2017

Categorisation:

  • Format
    • Presentation
  • Language
    • English
  • UEG Week Pathway
    • Chairman's Choice
    • Hepatobiliary
    • Primary Care
  • Year
    • 2017